Picture of Bio Solution Co logo

086820 Bio Solution Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Bio Solution Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-698-1,800-1,685-8,087-1,249
Depreciation
Amortisation
Non-Cash Items-896-9131983,503-2,713
Unusual Items
Other Non-Cash Items
Changes in Working Capital-2,498-774-197-1,3293,471
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-2,556-1,68683.3-3,8142,160
Capital Expenditures-2,478-2,505-663-4,085-1,159
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items3,2746,261-16,535-8,072-8,532
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities7963,756-17,199-12,157-9,690
Financing Cash Flow Items-1.21121,2991,046517
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities492-17242,642416-442
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-1,2641,88325,564-15,513-7,958